A new way to deliver psychiatric meds.
Levin-Epstein
Michael
M
levin-epstein0806@behavioral.net
D000279:Administration, Cutaneous; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage* / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D012642:Selegiline / Q000008:administration & dosage* / Q000627:therapeutic use; D014481:United States
D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D008774:Methylphenidate; D012642:Selegiline